Skip to main content

LICR CHARITABLE TRUST

EIN: 98-6039547New York, NYZIP: 10016

Mission

The organization is a Bermudian trust whose mission is to operate in connection with the Ludwig Institute for Cancer Research Ltd ("the Institute"), a Swiss not-for-profit organization, by maintaining oversight of the management of the Institute's programs and operations.

Financials

YearRevenueExpensesAssets
2023$150k$0$3.1M
2022$156k$0$3.4M

Compensation

2023

Edward A McDermott Jr
$52,788
$0
$0
$146,441
Sir John Bell
$0
$0
$0
$52,788
Conyers Trust Company (Bermuda) Ltd
$0
$0
$0
$52,788
John L Notter
$0
$0
$0
$52,788
John D Gordan III
$0
$0
$0
$52,788
Dr Jedd D Wolchok
$0
$0
$0
$52,788

2022

Edward A McDermott Jr
$48,876
$0
$0
$150,346
John L Notter
$0
$0
$0
$48,876
John D Gordan III
$0
$0
$0
$48,876
Dr Jedd D Wolchok
$0
$0
$0
$48,876
Sir John Bell
$0
$0
$0
$48,876
Conyers Trust Company (Bermuda) Ltd
$0
$0
$0
$48,876

Explore related organizations

Similar Organizations

ULEC LEVERAGE INC

New York, NY

$155k revenue
Similar sector (T)Very similar revenue ($155k vs $150k)Same state (New York)Comparable compensation levels
$158k revenue
Similar sector (T)Very similar revenue ($158k vs $150k)Same state (New York)
$163k revenue
Similar sector (T)Very similar revenue ($163k vs $150k)Same state (New York)
$139k revenue
Similar sector (T)Very similar revenue ($139k vs $150k)Same state (New York)
Similar sector (T)Similar revenue ($131k vs $150k)Same state (New York)Similar median compensation ($46k vs $53k)
$156k revenue
Similar sector (T)Very similar revenue ($156k vs $150k)Same state (New York)
$160k revenue
Similar sector (T)Very similar revenue ($160k vs $150k)Same state (New York)
$145k revenue
Similar sector (T)Very similar revenue ($145k vs $150k)Same state (New York)
$149k revenue
Similar sector (T)Very similar revenue ($149k vs $150k)Same state (New York)
MAVIK MISSION LTD

New York, NY

$150k revenue
Similar sector (T)Very similar revenue ($150k vs $150k)Same state (New York)
Data from IRS Form 990 filings (2022-2023).